Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes

Summary: We employed a dose-escalation regimen in rhesus macaques to deliver glycosylated IL-7, a cytokine critical for development and maintenance of T lymphocytes. IL-7 increased proliferation and survival of T cells and triggered several chemokines and cytokines. Induction of CXCL13 in lymph node...

Full description

Bibliographic Details
Main Authors: Hrishikesh Pandit, Antonio Valentin, Matthew Angel, Claire Deleage, Cristina Bergamaschi, Jenifer Bear, Raymond Sowder, Barbara K. Felber, George N. Pavlakis
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223000068
_version_ 1797903407958196224
author Hrishikesh Pandit
Antonio Valentin
Matthew Angel
Claire Deleage
Cristina Bergamaschi
Jenifer Bear
Raymond Sowder
Barbara K. Felber
George N. Pavlakis
author_facet Hrishikesh Pandit
Antonio Valentin
Matthew Angel
Claire Deleage
Cristina Bergamaschi
Jenifer Bear
Raymond Sowder
Barbara K. Felber
George N. Pavlakis
author_sort Hrishikesh Pandit
collection DOAJ
description Summary: We employed a dose-escalation regimen in rhesus macaques to deliver glycosylated IL-7, a cytokine critical for development and maintenance of T lymphocytes. IL-7 increased proliferation and survival of T cells and triggered several chemokines and cytokines. Induction of CXCL13 in lymph nodes (LNs) led to a remarkable increase of B cells in the LNs, proliferation of germinal center follicular T helper cells and elevated IL-21 levels suggesting an increase in follicle activity. Transcriptomics analysis showed induction of IRF-7 and Flt3L, which was linked to increased frequency of circulating plasmacytoid dendritic cells (pDCs) on IL-7 treatment. These pDCs expressed higher levels of CCR7, homed to LNs, and were associated with upregulation of type-1 interferon gene signature and increased production of IFN-α2a on TLR stimulation. Superior effects and dose-sparing advantage was observed by the step-dose regimen. Thus, IL-7 treatment leads to systemic effects involving both lymphoid and myeloid compartments.
first_indexed 2024-04-10T09:32:24Z
format Article
id doaj.art-d3af30d85067445a9fb29a6876052178
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-04-10T09:32:24Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-d3af30d85067445a9fb29a68760521782023-02-19T04:26:35ZengElsevieriScience2589-00422023-02-01262105929Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodesHrishikesh Pandit0Antonio Valentin1Matthew Angel2Claire Deleage3Cristina Bergamaschi4Jenifer Bear5Raymond Sowder6Barbara K. Felber7George N. Pavlakis8Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USAHuman Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USAVaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Center for Cancer Research Collaborative Bioinformatics Resource, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USAAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USAHuman Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USAHuman Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USAAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USAHuman Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USAHuman Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA; Corresponding authorSummary: We employed a dose-escalation regimen in rhesus macaques to deliver glycosylated IL-7, a cytokine critical for development and maintenance of T lymphocytes. IL-7 increased proliferation and survival of T cells and triggered several chemokines and cytokines. Induction of CXCL13 in lymph nodes (LNs) led to a remarkable increase of B cells in the LNs, proliferation of germinal center follicular T helper cells and elevated IL-21 levels suggesting an increase in follicle activity. Transcriptomics analysis showed induction of IRF-7 and Flt3L, which was linked to increased frequency of circulating plasmacytoid dendritic cells (pDCs) on IL-7 treatment. These pDCs expressed higher levels of CCR7, homed to LNs, and were associated with upregulation of type-1 interferon gene signature and increased production of IFN-α2a on TLR stimulation. Superior effects and dose-sparing advantage was observed by the step-dose regimen. Thus, IL-7 treatment leads to systemic effects involving both lymphoid and myeloid compartments.http://www.sciencedirect.com/science/article/pii/S2589004223000068Immune systemImmune responseComponents of the immune system
spellingShingle Hrishikesh Pandit
Antonio Valentin
Matthew Angel
Claire Deleage
Cristina Bergamaschi
Jenifer Bear
Raymond Sowder
Barbara K. Felber
George N. Pavlakis
Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes
iScience
Immune system
Immune response
Components of the immune system
title Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes
title_full Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes
title_fullStr Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes
title_full_unstemmed Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes
title_short Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes
title_sort step dose il 7 treatment promotes systemic expansion of t cells and alters immune cell landscape in blood and lymph nodes
topic Immune system
Immune response
Components of the immune system
url http://www.sciencedirect.com/science/article/pii/S2589004223000068
work_keys_str_mv AT hrishikeshpandit stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT antoniovalentin stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT matthewangel stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT clairedeleage stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT cristinabergamaschi stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT jeniferbear stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT raymondsowder stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT barbarakfelber stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes
AT georgenpavlakis stepdoseil7treatmentpromotessystemicexpansionoftcellsandaltersimmunecelllandscapeinbloodandlymphnodes